Corporate Business Development - QIAGEN

Commercial opportunities

To continue to meet and exceed customer expectations in our developing commercial markets, QIAGEN plans to optimize and diversify its technology interests in the following areas:

  • Novel technologies for handling and preparing samples prior to analysis of nucleic acids and proteins
  • Fractionation, enrichment, and depletion technologies
  • Amplification technologies
  • Storage, retrieval, and transportation solutions
  • Molecular testing, clinical research, and diagnostics using nucleic acids
  • RNAi synthesis, design, modification, and delivery
  • Gene expression at the RNA and protein level
  • General molecular biology research
Business and technology development
If you know of any product/service development opportunities in the above fields, we would be very interested in hearing from you.
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.